Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01151280 · ClinicalTrials.gov registry record · NA
WallFlex Biliary Post Liver Transplant IDE Pilot
A NA study of Anastomotic Biliary Stricture Post Orthotopic Liver Transplant, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT01151280 is a NA study of Anastomotic Biliary Stricture Post Orthotopic Liver Transplant that has completed, run by Boston Scientific Corporation. The registered enrollment target is 10 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT01151280, a NA study of Anastomotic Biliary Stricture Post Orthotopic Liver Transplant, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to demonstrate effectiveness of the WallFlex Biliary RX Fully Covered Stent for anastomotic biliary strictures in post-orthotopic liver transplant (OLT) patients.
Conditions Studied
Interventions
- DEVICE WallFlex Biliary Fully Covered Stent
Study Locations (2)
New York
- Mount Sinai Medical Center - New York
Ohio
- Mansour Parsi, MD - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01151280
The ClinicalTrials.gov registry entry for NCT01151280 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anastomotic Biliary Stricture Post Orthotopic Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which WallFlex Biliary Fully Covered Stent is the first listed.
NCT01151280 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT01151280 about?
NCT01151280 is a clinical study titled "WallFlex Biliary Post Liver Transplant IDE Pilot". The primary objective of this study is to demonstrate effectiveness of the WallFlex Biliary RX Fully Covered Stent for anastomotic biliary strictures in post-orthotopic liver transplant (OLT) patients.
What is the current status of trial NCT01151280?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2009-10. Estimated completion is 2012-12.
What conditions does trial NCT01151280 study?
This clinical trial studies the following conditions: Anastomotic Biliary Stricture Post Orthotopic Liver Transplant.
What interventions are being tested in trial NCT01151280?
The interventions under investigation include: WallFlex Biliary Fully Covered Stent (DEVICE).
Who is sponsoring clinical trial NCT01151280?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01151280 being conducted?
This trial has 2 study locations across New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.